PHR Phreesia, Inc.
Healthcare$8.98+0.00%OpenMarket Cap: $554.7M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$21.86
Target (Median)
$24.00
Target Range
$9.00 - $33.00
Upside from current price: 143.4%
Rating Distribution
5 Strong Buy10 Buy7 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-20 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-05-15 | Barclays | downgrade | Equal Weight | Overweight |
| 2026-04-13 | Keybanc | maintain | Overweight | Overweight |
| 2026-04-01 | Citizens | downgrade | Market Perform | Market Outperform |
| 2026-03-31 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-31 | JP Morgan | downgrade | Neutral | Overweight |
| 2026-03-31 | Citigroup | downgrade | Neutral | Buy |
| 2026-03-31 | BMO Capital | maintain | Outperform | Outperform |
| 2026-03-31 | Needham | maintain | Buy | Buy |
| 2026-03-31 | Stephens & Co. | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Sun Jan 31 | $0.52 | $552.1M | 8 |
| Mon Jan 31 | $0.55 | $541.4M | 7 |
| Wed Jan 31 | $0.68 | $567.7M | 4 |
| Thu Jan 31 | $0.88 | $538.5M | 2 |